Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Identification of NS5B resistance-associated mutations in hepatitis C virus circulating in treatment-naïve Cameroonian patients
IJID Regions
March 2026
Mounchili-Njifon A.
Open Access
Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country
Journal of Clinical Virology Plus
August 2024
Tantuoyir M.M.
Open Access
Negative Correlation of Interleukin-38 Serum Level with Alkaline Phosphatase and Persistent Hepatitis C Infection
Shiraz E Medical Journal
Sep 2022
Rokhtabnak N.
Open Access
An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study
International Journal of Drug Policy
April 2022
Mirzazadeh A.
Open Access
Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders
Virology Journal
December 2021
Sharafi H.
Open Access
First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients
BMC Gastroenterology
December 2021
Hasanshahi Z.
Open Access
An intervention to increase hepatitis C virus diagnosis and treatment uptake among people in custody in Iran
International Journal of Drug Policy
September 2021
Hariri S.
Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients
Current HIV Research
September 2021
Baesi K.
The efficacy and safety of sofosbuvir/daclatasvir fixed-dose combination in iranian hemodialysis patients with hepatitis C virus infection
Nephro Urology Monthly
May 2021
Ghanaat K.
Open Access
Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C
Plos One
April 2021
Ahmed H.R.
Open Access
Hepatitis C rapid point-of-care testing and laboratory-based non-invasive assessment of liver fibrosis among drug abusers: An experience from Iran
Archives of Iranian Medicine
February 2021
Hedayati-Moghaddam M.R.
Open Access
Assessing the quality of clinical practice guidelines in the middle east and north africa (Mena) region: A systematic review
Journal of Multidisciplinary Healthcare
2021
Almazrou S.H.
Open Access
Variations in IL-22, IL-27 and IL-35 serum levels in untreated and treated hepatitis C patients
European Cytokine Network
December 2020
Taghinejad A.
All Open Access, Green
Evaluating Drug Resistant Mutations to HCV NS3 Protease Inhibitors in Iranian Naïve Patients
International Journal of Peptide Research and Therapeutics
1 December 2020
Hashempour T.
Patient-reported outcomes of sleep, mood and quality of life after treatment of chronic hepatitis C infection using direct-acting antiviral agents
Clinical Microbiology and Infection
August 2020
Karimi-Sari H.
Open Access
The hepatitis C virus in Iran: Health policy, historical, ethical issues and future challenges
Journal of Preventive Medicine and Hygiene
2 April 2020
Behzadifar M.
Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation
Journal of Clinical Virology
March 2020
Jordan A.E.
All Open Access, Green
Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study
Caspian Journal of Internal Medicine
2020
Sharafi H.
Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran
Infection Genetics and Evolution
November 2019
Cuypers L.
Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population
Clinics and Research in Hepatology and Gastroenterology
October 2019
Ramezani A.
Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank
Microbial Drug Resistance
September 2019
Sharafi H.
Aflatoxin B1 exposure and the risk of hepatocellular carcinoma in Iranian carriers of viral hepatitis B and C
Toxin Reviews
3 July 2019
Habibi N.
Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting
Journal of Clinical Virology
April 2019
Sharafi H.
Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia
Journal of Medical Virology
March 2019
Khosravi A.